This is a working overview of Dihexa, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-10-19. Anything still debated is marked as such rather than presented as settled.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Analytical confirmation generally combines a separation method with a detection method. Reverse-phase high-performance liquid chromatography can assess purity, while mass spectrometry supports molecular identity. For research-grade material, a certificate of analysis may report a batch-specific purity value, but it does not guarantee biological activity or safety. Regulatory frameworks vary by country; many jurisdictions treat dihexa as a research chemical not intended for human consumption. Purchasers should verify local rules and supplier documentation. The absence of official standards makes independent testing and careful record-keeping important for laboratory work.
In laboratory settings, dihexa is typically handled as a research chemical rather than a pharmaceutical product. Suppliers may provide it as a lyophilized powder or in solution, and purity is often stated as a percentage determined by chromatographic analysis. Because independent verification is uncommon, researchers generally rely on certificates of analysis, which may include high-performance liquid chromatography and mass spectrometry data. The absence of pharmacopeial monographs means that identity, purity, and impurity profiles can vary between batches and suppliers.
Storage recommendations for peptides and peptide-like compounds usually emphasize low temperatures, desiccation, and protection from light. A common practice is to keep dry powder at -20 °C or below and to prepare solutions shortly before use. Repeated freeze-thaw cycles may degrade the material, so aliquoting is often advised. Solubility depends on the solvent; aqueous solubility may be limited, and organic solvents such as dimethyl sulfoxide are sometimes used for stock solutions. Stability data specific to dihexa are sparse, so general peptide handling guidelines are often applied instead.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 1401708-83-5 | Identifier used in chemical databases. |
| Common synonyms | P21; N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) | Names vary by supplier and publication. |
| Physical form | White to off-white powder | Lyophilized solid typical of peptides. |
| Solubility | Soluble in DMSO; limited in water | Aqueous preparation may need a co-solvent. |
| Storage | -20 °C, desiccated, protected from light | Reduce freeze-thaw cycles to maintain stability. |
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Dihexa is a synthetic peptide-like compound studied in preclinical research for its reported effects on synaptic growth and cognitive measures in animal models. It is often described as an analog of angiotensin IV, a naturally occurring peptide fragment. The compound has not been approved as a medicine in any major jurisdiction. Most public information comes from laboratory studies, patents, and online vendor listings rather than from large clinical trials. Its scientific status therefore differs from that of an established pharmaceutical.
Research interest in dihexa centers on its ability to promote synapse formation in cultured neurons and in some rodent experiments. These findings have been interpreted as a possible mechanism for learning and memory effects, but the evidence remains preliminary. Independent replication is limited, and study designs vary widely in species, duration, and outcome measures. Human data are scarce, so claims about cognitive enhancement in people are not supported by robust clinical evidence. The gap between laboratory signals and proven clinical benefit is substantial.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
Animal studies have examined dihexa in models of cognitive impairment, synaptic plasticity, and memory. Some reports describe improved performance on maze or avoidance tasks after administration. These findings are preclinical and often involve small samples, varied routes, and differing formulations. Results in rodents do not establish effects in humans. The absence of published randomized controlled trials in people is a major gap in the evidence base. Observational reports and user accounts do not substitute for controlled clinical data.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
The news reportedly left palaeontologist John Ostrom, who in the 1970s had pioneered the theory that birds evolved from dinosaurs, "in a state of shock." Ostrom later joined an international team of researchers who gathered in Beijing to examine the fossils; other team members included feather expert Alan Brush, fossil bird expert Larry Martin, and Peter Wellnhofer, an expert on the early bird Archaeopteryx. Three specimens have been assigned to Sinosauropteryx prima: the holotype GMV 2123 (and its counter slab [opposite face], NIGP 127586), NIGP 127587, and D 2141. Another specimen, IVPP V14202, was originally assigned to the genus in 2010, but was later designated as the holotype of a separate genus Huadanosaurus. The assignment of an additional larger specimen to S. prima, GMV 2124 (also known as NGMC 2124), was later found to be in error, and most likely belongs to Tyrannosauroidea. All of the fossils were found in the Jianshangou or Dawangzhangzi Beds of the Yixian Formation in the Beipiao and Lingyuan regions of Liaoning, China. These fossil beds have been dated to 124.6–122 million years ago, during the early Aptian stage of the Early Cretaceous.
Alison Elizabeth Larter (born February 28, 1976), is an American actress and former model. She portrayed fictional model Allegra Coleman in a 1996 Esquire magazine hoax and took on guest roles on several television shows in the 1990s. Her film debut in Varsity Blues (1999) was followed by a role in the horror film House on Haunted Hill (1999). She portrayed Clear Rivers in the Final Destination franchise (2000–2003) establishing her as a scream queen. Larter played supporting roles in Legally Blonde (2001), Jay and Silent Bob Strike Back (2001), and the romantic comedy A Lot Like Love (2005), and main roles in the Bollywood movie Marigold (2007) and the thriller Obsessed (2009). She achieved wider recognition for playing the dual roles of Niki Sanders and Tracy Strauss on the science fiction drama series Heroes (2006–2010) on NBC, and for portraying video game heroine Claire Redfield in three films of the Resident Evil film series (2007–2016). Larter costars as Angela Norris in the Paramount+ drama series Landman (2024). As of April 2017, Larter's films have grossed over $1.31 billion worldwide. Her presence in the media is reinforced by her appearances in lists compiled by Maxim, FHM, and Stuff as well as People's "Best Dressed List" in 2007. She published a cookbook, Kitchen Revelry: A Year of Festive Menus from My Home to Yours, in September 2013.
The level's designers initially created the traps in Ravenholm using "simple geometric shapes", before turning to concept artists to transform the ideas into more detailed and realistic concepts. It is generally believed by fans and critics that Ravenholm was partially inspired by a level of the 1998 video game Thief: The Dark Project known as the “Sealed Section", as Marc Laidlaw, who wrote the plot of Half-Life 2, was personally a fan of the game. In the level, the player traverses through a quarter of a large city which has become infested by the undead, which stands in contrast to the technologically advanced neighbourhoods surrounding it. However, unlike the Thief level, the player has not yet encountered overt horror tropes in Half-Life 2 prior to arriving at Ravenholm.
Since 28 February 2026, the United States and Israel have been at war with Iran and its regional allies. The war follows the Twelve-Day War in June 2025 and sporadic fighting during the Middle Eastern crisis sparked by the Gaza war (2023–present). Amid ongoing US–Iran negotiations regarding Iran's nuclear program, the war began when the US and Israel conducted hundreds of air strikes on targets across Iran, including strikes that assassinated Supreme Leader Ali Khamenei alongside several other Iranian officials. American rationale for initiating the war included regime change, preventing Iran from obtaining a nuclear weapon, a response to the massacre of several if not tens of thousands of anti-government protesters in Iran, and taking Iran's oil and gas resources. Critics have rejected these justifications, maintaining that the attack initiated a war of aggression, in violation of international law. Later war goals focused on nuclear negotiations and reopening the Strait of Hormuz. Public opinion was opposed to the war in the United States and in many other countries, leading to widespread disapproval for Donald Trump and declining views of the US and Israel around the world. The war was preceded in January–February 2026 by the largest US military buildup in the region since the 2003 invasion of Iraq.
In 2024, Albirex Niigata Singapore underwent localisation with players now predominantly Singaporean. This as well as the exit of DPMM FC means that from the 2025–26 season, all participants of the Singapore Premier League are local clubs. In recent years, foreign clubs from other countries have also been invited to participate in the Singapore Cup. The most recent entrant was BG Pathum United of the Thai League 1 at the 2024–25 Singapore Cup.
Sources: en.wikipedia.org
White for hydrogen Black for carbon Blue for nitrogen Red for oxygen Deep yellow for sulfur Purple for phosphorus Light, medium, medium dark, and dark green for the halogens (F, Cl, Br, I) Silver for metals (Co, Fe, Ni, Cu)
Moscow is situated on the banks of the Moskva River, which flows for about 500 kilometers (310 mi) through the East European Plain in Central Russia, not far from the natural border of the forest and the forest-steppe zone. A total of 49 bridges span the river and its canals within city limits. Moscow's elevation at the All-Russia Exhibition Center (VVC)—where the leading Moscow weather station is located—is 156 meters (512 ft). Teplostan Upland is the city's highest point at 255 meters (837 ft). The width of the city (excluding the MKAD) from west to east is 39.7 kilometers (24.7 mi), and the length from north to south is 51.8 kilometers (32.2 mi).
=== Related practices === Acupressure, a non-invasive form of bodywork, uses physical pressure applied to acupressure points by the hand or elbow, or with various devices. Acupuncture is often accompanied by moxibustion, the burning of cone-shaped preparations of moxa (made from dried mugwort) on or near the skin, often but not always near or on an acupuncture point. Traditionally, acupuncture was used to treat acute conditions while moxibustion was used for chronic diseases. Moxibustion could be direct (the cone was placed directly on the skin and allowed to burn the skin, producing a blister and eventually a scar), or indirect (either a cone of moxa was placed on a slice of garlic, ginger or other vegetable, or a cylinder of moxa was held above the skin, close enough to either warm or burn it). Cupping therapy is an ancient Chinese form of alternative medicine in which a local suction is created on the skin; practitioners believe this mobilizes blood flow in order to promote healing. Tui na is a TCM method of attempting to stimulate the flow of qi by various bare-handed techniques that do not involve needles. Electroacupuncture is a form of acupuncture in which acupuncture needles are attached to a device that generates continuous electric pulses (this has been described as "essentially transdermal electrical nerve stimulation [TENS] masquerading as acupuncture"). Fire needle acupuncture also known as fire needling is a technique which involves quickly inserting a flame-heated needle into areas on the body.
=== Oman === In Dhofar, Oman, frankincense species grow north of Salalah. It was traded in the ancient coastal city of Sumhuram, now Khor Rori, and Al-Baleed, an ancient port. In 2000, UNESCO inscribed the sites as a World Heritage Site Land of Frankincense.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.
No. Regulatory agencies have not approved dihexa for human use. It is sold as a research chemical in some markets, and human safety and efficacy data are lacking.
Laboratory studies have examined its effects on synapse formation and cognitive tasks in animals. These are early-stage findings. They do not prove benefits or safety in people.
Dry powder is usually kept frozen, desiccated, and protected from light. Solutions are often aliquoted to avoid repeated freeze-thaw cycles. Specific stability data for dihexa are limited, so general peptide storage practices are commonly used.